Skip to content
Sign in
Corporate VCBacked 1 network startup

Pulmuone

Korean food group's corporate investor; the only recorded deal is Yo-Kai Express's Series A, an automated ramen vending company.

Seoul, South Korea
Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
3most often with Chikaranomoto Holdings (Ippudo)

How they invest

The row lists only Agri & FoodTech. Its single network deal (Yo-Kai Express) suggests interest in food-tech that can extend Pulmuone's products into new channels (automated food service). Thesis and ticket are otherwise undocumented.

Stage and ticket

Unknown; participated in a Series A (2022).

Geography

Unknown; HQ Seoul, observed deal in a US/Japan company.

What makes them say yes

  • Food-tech that creates a distribution channel for packaged food (inferred)
  • Products with food-safety or health positioning (inferred)
  • Corporate-pilot readiness

Red flags

  • Non-food sectors
  • Undocumented thesis: other preferences unknown

Sectors

  • Agri & FoodTech

Stages

Not published

Geographies

Not published

How to approach

Yo-Kai Express is the warm path; Plug and Play and Japan Tobacco co-invested. Pitch as a strategic partnership (pilot or distribution) first, equity second.

Portfolio

1 network startup · no other company

One food-automation deal; strategic rather than financial pattern.

Gaps in the portfolio

  • Food safety
  • Functional/medical nutrition
  • Alternative proteins

Network startups

  • Yo-Kai Express Inc.SWC 2026 Top 10

    Robotic 'autonomous restaurants' serving hot ramen in about 90 seconds, with 250+ machines in US, Japanese and Taiwanese transit hubs.

    United States · Agri & FoodTech

Network startups that fit

3 analysed

bioMérieux spin-off miniaturising allergen testing into a pocket lab; strong backers, but still pre-product.

Pocket lab that detects allergens in food: a food-safety technology a large food manufacturer could pilot or distribute.

40%confidence

Evidence from the records

  • “Food allergen detection / food safety”
  • “Portable mini-lab still in development”
Intro path
Co-investors bioMérieux, Bpifrance, Demeter.
First step
Propose a Pulmuone product-testing pilot.

Italian “Food as Medicine” company selling patented pre/probiotic functional foods for digestive disorders, intolerances and diabetes.

Italian 'food as medicine' brands for digestive disorders and diabetes, aligned with health-positioned food portfolios.

35%confidence

Evidence from the records

  • “Functional foods / “Food as Medicine””
  • “Agri & FoodTech”
First step
Explore Korean distribution or licensing with Pulmuone.

Plant-based medical food Seracal using a structured lipid matrix to improve fat and nutrient absorption in malabsorption patients.

Medical nutrition for malabsorption: a niche health-food product with clinical backing but no sales yet.

25%confidence

Evidence from the records

  • “Medical nutrition / malabsorption”
  • “Seracal offered only as samples”
Intro path
Co-investors Ulu Ventures, Robin Hood Ventures, The MBA Fund.
First step
Pitch after Vytala lands its first commercial customer.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Chikaranomoto Holdings (Ippudo), Japan Tobacco (JT), and Plug and Play

Sources

  1. 1jstories.media/article/yo-kai-express
  2. 2thespoon.tech/autonomous-restaurant-startup-yo-kai-express-expands-in-jap

Profile compiled from public sources. Unknown fields are left empty rather than estimated.